Severe Patients Uncontrolled on Ics 2Nd Controller
Research payments
$43,895
Through program year 2019, $43,895 in research payments was reported against Severe Patients Uncontrolled on Ics 2Nd Controller, across 19 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $43,895 | 19 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Shahrukh Kureishy McKinney, TX Named on 4 payments
- Steven Meltzer Long Beach, CA Named on 2 payments
- David Elkayam Bellingham, WA Named on 2 payments
- Timothy Moriarty Panama City, FL Named on 1 payment
- Neil Kao Greenville, SC Named on 1 payment
- Larry Posner Napa, CA Named on 1 payment
- Nabil Andrawis Burke, VA Named on 1 payment
- Ricardo Tan Sherman Oaks, CA Named on 1 payment
- Linda Ford Bellevue, NE Named on 1 payment
- Mitchell Lee Wilmington, NC Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.